Press releases and news

News: Uppsala, on 17 June 2021. Senzimes distributor comments on the field development following the new guidelines. In recent communications information on the new launch of the AAGBI guidelines were referenced. These guidelines state that in the UK...
News: Uppsala, on 22 May 2021. Senzime today announces that the Association of Anaesthetists in the UK and Ireland has issued new standards for neuromuscular monitoring stating that Quantitative neuromuscular monitoring is essential and should be available...
The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 11 May 2021 by postal voting whereby the shareholders primarily resolved on the following matters. Annual report and results The annual...
2021-05-06 08:45 Interim report January – March 2021 Regulatory Interim
Press release: Uppsala, May 6, 2021. Senzime AB’s (publ) Interim Report for January-March 2021 is now available on the company’s website www.senzime.com. Financial information January – March Despite the fact that Covid-19 continued...
To take advantage of the opportunities the need for adequate anesthesia monitoring entails, Senzime is now expanding its commercial capacity in the US market through further recruitment of its own sales staff and by entering into distribution agreement...
2021-04-19 08:54 Senzime Annual Report 2020 Regulatory Annual
For further information, please contact: Pia Renaudin, CEO of Senzime AB Tel: +46 (0)70-813 34 17, email: pia.renaudin@senzime.com Erik Bergman, CFO Tel: +46 (0)73-258 81 59, e-post: erik.bergman@senzime.com TO THE EDITORS About Senzime Senzime develops...
Notice etc. Shareholders who wish to participate at the annual general meeting must: register with the Company no later than Monday 10 May 2021 by submitting a postal voting form in accordance with the instructions below to be received by the Company...
As stated in the article, “Comparison of the TetraGraph and the TOFscan for monitoring recovery from neuromuscular blockade in the Post Anesthesia Care Unit”[1], the lead author, Dr. J. Ross Renew reports that the number of patients arriving...
Election of new member of the Board of Directors The extra general meeting resolved to elect Eva Walde as new member of the Board of Directors. For further information, please contact: Pia Renaudin, CEO of Senzime AB Tel: +46 708-13 34 17, e-mail: pia.renaudin@senzime.com...
There are more than 3,000 hospitals in South Korea and more than 700 000 operations are performed annually where anesthesia and muscle relaxants are used. “This is a huge leap for patient safety and an acknowledgement of the need to monitor patients...